tirzepatide or semiglutide vs Semaglutide: what's the difference? 👀 Both are game-changers in metabolic medicine — but they don't work exactly the same: ✨ Semaglutide → Mimics GLP-1 only → Reduces appetite → Slows Tirzepatide vs Semaglutide: 2026 Clinical

Unlike traditional GLP-1 peptides, Retatrutide targets three metabolic receptor pathways: GLP-1 (Glucagon-Like Peptide-1) GIP (Glucose-Dependent Insulinotropic Polypeptide) Glucagon receptors Its triple-agonist activity is being researched for its potential role in: Appetite regulation and satiety Reduced food cravings and food noise Metabolic efficiency Energy expenditure and fat metabolism Insulin sensitivity and glucose regulation Long-term body weight management support Many individuals researching Retatrutide report: Strong appetite suppression Reduced snacking tendencies Increased feelings of fullness Consistent metabolic support Significant body composition changes over time Because Retatrutide also activates glucagon receptors, ongoing research is exploring its potential role in increasing metabolic activity and energy expenditure beyond traditional GLP-1 pathways

Tirzepatide is a dual-receptor medication that activates both GLP-1 and GIP pathways and produces average weight loss of about 21% of body weight

J Pediatr.Hematol.Oncol

This can drive a relentless pursuit of weight losseven at the cost of their mental and emotional well-being